Skip to main content
. Author manuscript; available in PMC: 2019 Jun 20.
Published in final edited form as: ACS Chem Neurosci. 2018 Apr 6;9(6):1327–1337. doi: 10.1021/acschemneuro.7b00510

Figure 1. L-SPD acts as a full and partial agonist at the D1 and D5 receptor, respectively, in comparison to dopamine (DA).

Figure 1.

DA and L-SPD stimulated cAMP formation in HEK cells expressing D1 or D5 receptors in a dose-dependent manner. cAMP levels were examined as previously described, and data were normalized to DA at 10−5 M. Potencies and efficacies were determined by curve fitting and are shown in Table 2. Data represent mean ± S.E.M. (n = 3–4).